These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37584233)

  • 1. Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders.
    Lakkireddy D; Nielsen-Kudsk JE; Windecker S; Thaler D; Price MJ; Gambhir A; Gupta N; Koulogiannis K; Marcoff L; Mediratta A; Anderson JA; Gage R; Ellis CR
    Europace; 2023 Aug; 25(9):. PubMed ID: 37584233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
    Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
    J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.
    Price MJ; Ellis CR; Nielsen-Kudsk JE; Thaler D; Gupta N; Koulogiannis K; Anderson JA; Gage R; Lakkireddy D
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2127-2138. PubMed ID: 36357016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; O'Brien L; Windecker S
    Circulation; 2021 Nov; 144(19):1543-1552. PubMed ID: 34459659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.
    Korsholm K; Kramer A; Andersen A; Saw J; Nørgaard BL; Jensen JM; Nielsen-Kudsk JE
    J Interv Card Electrophysiol; 2023 Mar; 66(2):391-401. PubMed ID: 35951214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial).
    Lakkireddy D; Windecker S; Thaler D; Søndergaard L; Carroll J; Gold MR; Guo H; Brunner KJ; Hermiller JB; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; Levine J
    Am Heart J; 2019 May; 211():45-53. PubMed ID: 30831333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
    PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Gambhir A; Hermiller J; Nielsen-Kudsk JE; Worthley S; Nair D; Schmidt B; Horton R; Gupta N; Anderson JA; Gage R; Alkhouli M; Windecker S
    JACC Cardiovasc Interv; 2023 Aug; 16(15):1902-1913. PubMed ID: 37587599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet.
    Kleinecke C; Park JW; Gödde M; Zintl K; Schnupp S; Brachmann J
    Cardiol J; 2017; 24(2):131-138. PubMed ID: 28198520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial.
    Alkhouli M; Russo AM; Thaler D; Windecker S; Anderson JA; Gage R; Lakkireddy D
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2143-2155. PubMed ID: 36357018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhu MZ; Song H; Song GM; Bai X
    Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of percutaneous left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation: Asia-Pacific experience.
    Chiu FC; Huang PS; Chen JJ; Hwang JJ; Tsai CT
    J Formos Med Assoc; 2022 Aug; 121(8):1442-1449. PubMed ID: 34799213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-by-Side Comparison of LAA Occlusion Performance With the Amplatzer Cardiac Plug and Amplatzer Amulet.
    Abualsaud A; Freixa X; Tzikas A; Chan J; Garceau P; Basmadjian A; Ibrahim R
    J Invasive Cardiol; 2016 Jan; 28(1):34-8. PubMed ID: 26716593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Predictors, and Clinical Outcomes of Device-Related Thrombus in the Amulet IDE Trial.
    Schmidt B; Nielsen-Kudsk JE; Ellis CR; Thaler D; Sabir SA; Gambhir A; Landmesser U; Shah N; Gray W; Swarup V; Lim DS; Koulogiannis K; Anderson JA; Gage R; Lakkireddy D
    JACC Clin Electrophysiol; 2023 Jan; 9(1):96-107. PubMed ID: 36697204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.